Tixagevimab Withdrawn Phase 2 Trials for Chronic Lymphocytic Leukemia / Coronavirus Disease 2019 (COVID‑19) Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT05465876Passive Antibodies Against COVID-19 With EVUSHELD in Vaccine Non-responsive CLL